Reynaert
Johan Lieven Hendrik Reynaert, Bissegem BE
Patent application number | Description | Published |
---|---|---|
20120319093 | ORGANIC ELECTROLUMINESCENCE GENERATING DEVICES - An electroluminescence generating device comprising a channel of organic semiconductor material, said channel being able to carry both types of charge carriers, said charge carriers being electrons and holes; an electron electrode, said electron electrode being in contact with said channel and positioned on top of a first side of said channel layer or within said channel layer, said electron electrode being able to inject electrons in said channel layer; a hole electrode, said hole electrode being spaced apart from said electron electrode, said hole channel and positioned on top of within said channel layer, said hole electrode being able to inject holes into said channel; a control electrode positioned on said first side or on a second side of said channel; whereby light emission of said electroluminescence generating device can be acquired by applying an electrical potential difference between said electron electrode and said hole electrode. | 12-20-2012 |
20130285028 | ORGANIC ELECTROLUMINESCENCE GENERATING DEVICES - An electroluminescence generating device comprising a channel of organic semiconductor material, said channel being able to carry both types of charge carriers, said charge carriers being electrons and holes; an electron electrode, said electron electrode being in contact with said channel and positioned on top of a first side of said channel layer or within said channel layer, said electron electrode being able to inject electrons in said channel layer; a hole electrode, said hole electrode being spaced apart from said electron electrode, said hole channel and positioned on top of within said channel layer, said hole electrode being able to inject holes into said channel; a control electrode positioned on said first side or on a second side of said channel; whereby light emission of said electroluminescence generating device can be acquired by applying an electrical potential difference between said electron electrode and said hole electrode. | 10-31-2013 |
20140151673 | ORGANIC ELECTROLUMINESCENCE GENERATING DEVICES - An electroluminescence generating device comprising a channel of organic semiconductor material, said channel being able to carry both types of charge carriers, said charge carriers being electrons and holes; an electron electrode, said electron electrode being in contact with said channel and positioned on top of a first side of said channel layer or within said channel layer, said electron electrode being able to inject electrons in said channel layer; a hole electrode, said hole electrode being spaced apart from said electron electrode, said hole channel and positioned on top of within said channel layer, said hole electrode being able to inject holes into said channel; a control electrode positioned on said first side or on a second side of said channel; whereby light emission of said electroluminescence generating device can be acquired by applying an electrical potential difference between said electron electrode and said hole electrode. | 06-05-2014 |
Niki Reynaert, Maasmechelen BE
Patent application number | Description | Published |
---|---|---|
20140140975 | TREATMENTS INVOLVING GLUTAREDOXINS AND SIMILAR AGENTS - The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress condition, for example, airway inflammation or asthma. In some embodiments, a glutaredoxin may be used to treat a subject. Also provided in certain aspects of the present invention are kits for therapies involving glutaredoxins, methods for promoting such therapies, and the like. | 05-22-2014 |
20150056633 | DETECTION OF GLUTATHIONYLATED PROTEINS - The present invention, in some aspects, relates to systems and methods for determining oxidized proteins, including glutathionylated proteins such as S-glutathionylated proteins. The systems and methods of the invention can be used in vitro (e.g., in cell or tissue culture) or in vivo, for example, to diagnose a person having an oxidative stress condition. For instance, in some cases, the invention can be used to spatially determine the location and/or concentration of oxidized proteins within cells and/or tissues (e.g., through visual detection). In one set of embodiments, a glutathionylated or otherwise oxidized moiety on a protein may be reacted with a detection entity, which may be, for example, fluorescent, radioactive, electron-dense, able to bind to a signaling entity or a binding partner in order to produce a signal, etc. As a specific example, a glutathionylated moiety on a glutathionylated protein may be reacted with an alkylating agent to form an alkylthio moiety; the alkylthio moiety may include a detection entity or otherwise be able to interact with a signaling entity. In some embodiments, other moieties on the protein may be altered or blocked before reaction of the protein with the detection entity. Such moieties on the protein may be, for instance, non-oxidized or non-glutathionylated moieties able to react with the detection entity. As a particular example, in a protein containing a glutathionylated moiety and non-glutathionylated thiol moieties, the thiol moieties may first be altered or blocked prior to reaction of the protein with the detection entity. Also provided in certain aspects of the present invention are kits for determining oxidized proteins, which may include components such as detection entities, alkylating agents, blocking agents, reducing agents, signaling entities, binding partners, antibodies, instructions, and the like. | 02-26-2015 |
Niki Lea Reynaert, Maasmechelen BE
Patent application number | Description | Published |
---|---|---|
20100266566 | TREATMENTS INVOLVING GLUTAREDOXINS AND SIMILAR AGENTS - The present invention generally relates to treatments involving glutaredoxins. In one aspect, systems and methods of the invention can be used to treat a subject having an oxidative stress condition, for example, airway inflammation or asthma. In some embodiments, a glutaredoxin may be used to treat a subject. Also provided in certain aspects of the present invention are kits for therapies involving glutaredoxins, methods for promoting such therapies, and the like. | 10-21-2010 |
Patrick Reynaert, Aartselaar BE
Patent application number | Description | Published |
---|---|---|
20090184761 | AMPLIFIER MODULATION METHOD AND APPARATUS - One embodiment relates to a power amplifier that includes a switched mode power amplification stage. The power amplification stage has an output configured to provide an amplified output voltage as a function of a drive signal, where the drive signal fluctuates during a first time and is inactive during a second time. The power amplifier also includes impedance compensation circuitry coupled to the output of the power amplification stage. The impedance compensation circuitry can selectively alter an output impedance of the power amplification stage as a function of a control signal that is continuously de-asserted during the first time and continuously asserted during the second time. Other embodiments are also disclosed. | 07-23-2009 |
Patrick Reynaert, Vertrijk BE
Patent application number | Description | Published |
---|---|---|
20130265108 | Extremely High Frequency Dual-Mode Class AB Power Amplifier - An Extremely High Frequency (EHF) dual-mode PA with a power combiner is designed using 40-nm bulk CMOS technology. One of the unit PAs can be switched off for the low power applications. In the design, circuit level optimization and trade-off are performed to ensure the good performance in both modes. The PA achieves a P | 10-10-2013 |
20140176259 | Polyphase Filter for MM-Wave Frequencies Featuring Symmetric Layout - A two-stage, passive, RC polyphase filter for mm-wave quadrature LO generation is presented. The filter features an innovative, symmetrical layout structure, which is more robust to parasitics than the conventional layout. Layout parasitics which become important at mm-wave frequencies are identified and a compensated. Impedance variations and transfer functions are evaluated considering these dominant parasitics. More than 15 dB improvement in image rejection ratio is achieved in comparison with conventional layouts. Using the inventive techniques more than 35 dB of image rejection ratio over a bandwidth of 6 GHz is demonstrated in an outphasing transmitter at 60 GHz in 40 nm CMOS. | 06-26-2014 |
Peter Reynaert, Boortmeerbeek BE
Patent application number | Description | Published |
---|---|---|
20130053959 | Cross Pinning Guide Devices and Methods - Methods and devices are provided for implanting a cross-pin through a bone tunnel, such as in an arthroscopic surgical procedure. In general, the methods and devices allow a cross-pin hole to be formed in a medial side of a knee bone such that it intersects a bone tunnel formed in the knee bone. In one embodiment, a cross-pinning guide device is provided that can be configured to angularly position the cross-pin hole relative to the bone tunnel to allow the cross-pin hole to intersect the bone tunnel without passing through another side, e.g., a lateral side, of the knee bone. The knee bone can be a femur or a tibia such that the cross-pin hole and the bone tunnel can each be entirely formed in the femur or in the tibia. | 02-28-2013 |
20140081276 | CROSS PINNING GUIDE DEVICES AND METHODS - Methods and devices are provided for implanting a cross-pin through a bone tunnel, such as in an arthroscopic surgical procedure. In general, the methods and devices allow a cross-pin hole to be formed in a medial side of a knee bone such that it intersects a bone tunnel formed in the knee bone. In one embodiment, a cross-pinning guide device is provided that can be configured to angularly position the cross-pin hole relative to the bone tunnel to allow the cross-pin hole to intersect the bone tunnel without passing through another side, e.g., a lateral side, of the knee bone. The knee bone can be a femur or a tibia such that the cross-pin hole and the bone tunnel can each be entirely formed in the femur or in the tibia. | 03-20-2014 |